Cite
HARVARD Citation
Lavynenko, O. et al. (2022). Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT). Diabetes, obesity & metabolism. 24 (5), pp. 899-907. [Online].